Invested in PAK BioSolutions' $12M Series A.
JUN 17, 2024
Develops automated equipment and single-use consumables for end-to-end continuous biopharmaceutical manufacturing
Develops automated equipment and single-use consumables for end-to-end continuous biopharmaceutical manufacturing. Its systems integrate multiple purification operations to increase throughput and reduce facility capital costs and footprint, serving process development, pilot, and cGMP commercial production.